Records containing: Lung Diseases, Interstitial
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-04-15The Development and Pilot Testing of a Brief Shared Decision-Making Intervention to Improve Palliative Care Outcomes for Adults With Advanced Lung Disease
-
CLINICAL_TRIALS study record update · 2025-04-04A Randomised Clinical Trial of a Digital Self-management Package for People With Interstitial Lung Disease
-
CLINICAL_TRIALS study record update · 2025-02-21Using the Electronic Health Record to Identify and Promote Goals-of-Care Communication for Older Patients With Serious Illness
-
CLINICAL_TRIALS study record update · 2024-12-24Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest
-
CLINICAL_TRIALS study record update · 2024-12-10Expanded Access Use of OFEV (Nintedanib) in Non-IPF Interstitial Lung Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-11-21Assessment of the Oxygen Use and Future Outcomes Associated With Oxygen Use in Patient With Fibrotic ILD
-
CLINICAL_TRIALS study record update · 2024-11-19A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase 2/3 Study of Efficacy and Safety of Olokizumab in Subjects With Progressive Fibrosing Interstitial Lung Diseases
-
CLINICAL_TRIALS study record update · 2024-10-10Assessment of Interstitial Lung Disease in Rheumatoid Arthritis by Lung Ultrasound
-
CLINICAL_TRIALS study record update · 2024-09-19Incidence Probability of Progression to Progressive Fibrosing Interstitial Lung Diseases and Status of Management and Treatments in Patients With Fibrosing Interstitial Lung Diseases Other Than Idiopathic Pulmonary Fibrosis in Japan
-
CLINICAL_TRIALS study record update · 2024-07-01A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for Immune Checkpoint Blockade in Non-small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2024-04-29Epidemiology of Surfactant Protein-B Deficiency
-
CLINICAL_TRIALS study record update · 2024-03-12ClinicalTrials.gov study NCT00005295
-
CLINICAL_TRIALS study record update · 2024-03-12ClinicalTrials.gov study NCT00005290
-
CLINICAL_TRIALS study record update · 2024-02-20An Open-label Extension Trial of the Long Term Safety of Nintedanib in Patients With 'Systemic Sclerosis Associated Interstitial Lung Disease' (SSc-ILD)
-
CLINICAL_TRIALS study record update · 2024-02-14A Within-subject Device-setting Escalation Early Feasibility Study Evaluating the Safety, Tolerability, and Functionality of 3P-100 in Subjects With PH-ILD
-
CLINICAL_TRIALS study record update · 2024-01-12Assessment of Neuropsychiatric Function in Patients With Interstitial Lung Disease
-
CLINICAL_TRIALS study record update · 2023-12-15Evaluation of Physical Activity and Quality of Life in Fibrotic Lung Diseases After Initiating Anti-fibrotic Therapy and Pulmonary Rehabilitation
-
CLINICAL_TRIALS study record update · 2023-11-28Idiopathic Pulmonary Fibrosis and Serum Bank
-
CLINICAL_TRIALS study record update · 2023-11-27Intercostal and Quadriceps Femoris Muscles Oxygenation During Exercise in Patient With Fibrosing Interstitial Lung Diseases
-
CLINICAL_TRIALS study record update · 2023-09-13An Open-label Extension Trial of the Long Term Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
-
CLINICAL_TRIALS study record update · 2023-08-03The Effect of High Flow, Nasal Cannula Delivered Air in Patients With Interstitial Lung Disease - a Pilot Study
-
CLINICAL_TRIALS study record update · 2023-06-28A Phase 2, 24-Week, Randomized, Double-blind, Placebo-controlled, Multicenter Study, With an 80-Week Active Treatment Extension, to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2023-06-18Using Thoracic Ultrasound in a Rheumatological Setting to Detect Interstitial Lung Disease in Patients With Rheumatoid Arthritis: Protocol for a Cross-Sectional Diagnostic Test Accuracy Study. AURORA.
-
CLINICAL_TRIALS study record update · 2023-05-03Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases
-
CLINICAL_TRIALS study record update · 2023-01-31A Double Blind, Randomised, Placebo-controlled Trial to Evaluate the Dose-exposure and Safety of Nintedanib Per os on Top of Standard of Care for 24 Weeks, Followed by Open Label Treatment With Nintedanib of Variable Duration, in Children and Adolescents (6 to 17 Year-old) With Clinically Significant Fibrosing Interstitial Lung Disease